These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9035900)
1. Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions. Bui-Xuan B; Aupetit JF; Freysz M; Loufoua J; Faucon G; Timour Q Cardiovasc Res; 1996 Dec; 32(6):1056-63. PubMed ID: 9035900 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration. Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448 [TBL] [Abstract][Full Text] [Related]
3. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion. Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782 [TBL] [Abstract][Full Text] [Related]
4. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation. Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759 [TBL] [Abstract][Full Text] [Related]
5. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker. Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997 [TBL] [Abstract][Full Text] [Related]
6. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization. Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812 [TBL] [Abstract][Full Text] [Related]
7. Vulnerability to ventricular fibrillation related to ischaemia: comparison of the acute effects of beta-blockers and calcium antagonists. Aupetit JF; Timour Q; Freysz M; Loufoua-Moundanga J; Omar S; Chevrel G; Faucon G Arch Int Pharmacodyn Ther; 1994; 327(1):25-39. PubMed ID: 7944825 [TBL] [Abstract][Full Text] [Related]
8. Profibrillatory effects of lidocaine in the acutely ischemic porcine heart. Aupetit JF; Timour Q; Loufoua-Moundanga J; Barral-Cadière L; Lopez M; Freysz M; Faucon G J Cardiovasc Pharmacol; 1995 May; 25(5):810-6. PubMed ID: 7630159 [TBL] [Abstract][Full Text] [Related]
9. Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine. Freysz M; Timour Q; Bertrix L; Loufoua-Moundanga J; Omar S; Faucon G Acta Anaesthesiol Scand; 1993 May; 37(4):350-6. PubMed ID: 8322562 [TBL] [Abstract][Full Text] [Related]
10. The anti-arrhythmic effects of myocardial ischaemia. Relation to reperfusion arrhythmias? Podzuweit T; Binz KH; Nennstiel P; Flaig W Cardiovasc Res; 1989 Feb; 23(2):81-90. PubMed ID: 2550132 [TBL] [Abstract][Full Text] [Related]
11. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs. Timour Q; Aupetit JF; Loufoua-Moundanga J; Kioueh I; Omar S; Chevrel G; Faucon G Fundam Clin Pharmacol; 1992; 6(4-5):159-67. PubMed ID: 1427561 [TBL] [Abstract][Full Text] [Related]
12. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model. Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223 [TBL] [Abstract][Full Text] [Related]
13. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments]. Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877 [TBL] [Abstract][Full Text] [Related]
14. Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold. Freysz M; Timour Q; Bertrix L; Loufoua J; Aupetit JF; Faucon G Anesth Analg; 1995 Apr; 80(4):657-63. PubMed ID: 7893014 [TBL] [Abstract][Full Text] [Related]
15. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs. Andersen HR; Wiggers H; Knudsen LL; Simonsen I; Thomsen PE; Christiansen N Cardiovasc Res; 1994 Nov; 28(11):1635-40. PubMed ID: 7842456 [TBL] [Abstract][Full Text] [Related]
16. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ. Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551 [TBL] [Abstract][Full Text] [Related]
17. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload. Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452 [TBL] [Abstract][Full Text] [Related]
18. Effect of isoprenaline chronic stimulation on APD restitution and ventricular arrhythmogenesis. Qin M; Liu T; Hu H; Wang T; Yu S; Huang C J Cardiol; 2013 Feb; 61(2):162-8. PubMed ID: 23085034 [TBL] [Abstract][Full Text] [Related]
19. β-Adrenergic stimulation and rapid pacing mutually promote heterogeneous electrical failure and ventricular fibrillation in the globally ischemic heart. Garg V; Taylor T; Warren M; Venable P; Sciuto K; Shibayama J; Zaitsev A Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1155-70. PubMed ID: 25713306 [TBL] [Abstract][Full Text] [Related]
20. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Vegh A; Szekeres L; Parratt J Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]